Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 4;11(1):28.
doi: 10.3390/v11010028.

Viral Delivery Systems for CRISPR

Christine L Xu  1   2 , Merry Z C Ruan  3   4 , Vinit B Mahajan  5   6 , Stephen H Tsang  7   8   9
Affiliations
Review

Viral Delivery Systems for CRISPR

Christine L Xu et al. Viruses. .

Abstract

The frontiers of precision medicine have been revolutionized by the development of Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR)/Cas9 as an editing tool. CRISPR/Cas9 has been used to develop animal models, understand disease mechanisms, and validate treatment targets. In addition, it is regarded as an effective tool for genome surgery when combined with viral delivery vectors. In this article, we will explore the various viral mechanisms for delivering CRISPR/Cas9 into tissues and cells, as well as the benefits and drawbacks of each method. We will also review the history and recent development of CRISPR and viral vectors and discuss their applications as a powerful tool in furthering our exploration of disease mechanisms and therapies.

Keywords: CRISPR; animal models; gene editing; gene therapy; viral vectors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ran F.A., Hsu P.D., Wright J., Agarwala V., Scott D.A., Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 2013;8:2281–2308. doi: 10.1038/nprot.2013.143. - DOI - PMC - PubMed
    1. Xu C.L., Park K.S., Tsang S.H. CRISPR/Cas9 genome surgery for retinal diseases. Drug Discov. Today Technol. 2018;28:23–32. doi: 10.1016/j.ddtec.2018.05.001. - DOI - PMC - PubMed
    1. Xu C.L., Cho G.Y., Sengillo J.D., Park K.S., Mahajan V.B., Tsang S.H. Translation of CRISPR Genome Surgery to the Bedside for Retinal Diseases. Front. Cell Dev. Biol. 2018;6:46. doi: 10.3389/fcell.2018.00046. - DOI - PMC - PubMed
    1. Shrock E., Guell M. CRISPR in Animals and Animal Models. Prog. Mol. Biol. Transl. Sci. 2017;152:95–114. doi: 10.1016/bs.pmbts.2017.07.010. - DOI - PubMed
    1. Hsu P.D., Lander E.S., Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 2014;157:1262–1278. doi: 10.1016/j.cell.2014.05.010. - DOI - PMC - PubMed

Publication types

LinkOut - more resources